[ESPR] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -9.14%
YoY- -10.38%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 14,409 3,833 981 0 0 0 0 -
PBT -69,386 -85,437 -68,377 -49,911 -45,219 -17,402 -12,801 32.50%
Tax 13,667 4,970 5,383 0 606 488 378 81.74%
NP -69,386 -85,437 -68,377 -49,911 -45,219 -17,402 -12,801 32.50%
Tax Rate - - - - - - - -
Total Cost 83,795 89,270 69,358 49,911 45,219 17,402 12,801 36.73%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -481.55 -2,228.99 -6,970.13 0.00 0.00 0.00 0.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -2.62 -3.07 -2.52 -1.86 -1.86 -0.77 -0.57 28.91%
EPS Diluted -2.62 -3.07 -2.52 -1.86 -1.86 -0.77 -0.57 28.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.